Minority recruitment in the prostate cancer prevention trial.

[1]  Barry R. Davis,et al.  Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. , 2000, JAMA.

[2]  C. Coltman,et al.  Underrepresentation of patients 65 years of age or older in cancer-treatment trials. , 1999, The New England journal of medicine.

[3]  J. Costantino,et al.  Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  P. Feigl,et al.  Prostate Cancer Prevention Trial (PCPT) Update , 1999, European Urology.

[5]  D. Hunninghake,et al.  Recruitment for controlled clinical trials: literature summary and annotated bibliography. , 1997, Controlled clinical trials.

[6]  E. Paskett,et al.  The recruitment of African-Americans to cancer prevention and control studies. , 1996, Preventive medicine.

[7]  I. Thompson,et al.  Screening for prostate cancer: opportunities for prevention. , 1996, Seminars in urologic oncology.

[8]  G. Swanson,et al.  Recruiting minorities into clinical trials: toward a participant-friendly system. , 1995, Journal of the National Cancer Institute.

[9]  O. Brawley,et al.  The Potential Application of Finasteride for Chemoprevention of Prostate Cancer , 1995, Annals of the New York Academy of Sciences.

[10]  T. Reynolds.  PCPT update: enrollment mounts, but minority participation lags. , 1994, Journal of the National Cancer Institute.

[11]  B. Kramer,et al.  5-Alpha-reductase inhibition and prostate cancer prevention. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  E. Sondik,et al.  Accrual of Patients to Randomized Clinical Trials: Factors Affecting Cancer Prevention and Control Research , 1994, International Journal of Technology Assessment in Health Care.

[13]  S. Millon-Underwood.  Determinants of participation in state‐of‐the‐art cancer prevention, early detection/screening, and treatment trials among African‐Americans , 1993, Cancer nursing.

[14]  Samuel Hellman,et al.  Important advances in oncology , 1991 .

[15]  J. Horm,et al.  Socioeconomic factors and cancer incidence among blacks and whites. , 1991, Journal of the National Cancer Institute.

[16]  C. K. Svensson,et al.  Representation of American blacks in clinical trials of new drugs. , 1989, JAMA.

[17]  Agras Ws,et al.  Recruitment: an introduction. , 1982, Circulation.